4BIO Capital is a venture capital firm investing in early-stage biotech and health tech companies. They focus on advanced therapies, including cell and gene therapy, RNA-based treatments, targeted therapies, and microbiome solutions. Their aim is to develop treatments for serious medical conditions and make these therapies accessible to all patients. The team, comprising experienced scientists and investors with over 250 published scientific articles, maintains a strong network in the advanced therapy sector to identify successful investment opportunities.
